CFO
NTR icon

Callan Family Office’s Nutrien NTR Stock Holding History

Callan Family Office’s Portfolio NTR Stock Details NTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Sell
4,289
-6,662
-61% -$466K 0.01% 1040
2026
Q1 		$825K Sell
10,951
-133
-1% -$9.48K 0.02% 614
2025
Q4 		$685K Buy
+11,084
New +$652K 0.01% 667

Other funds holding NTR

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Callan Family Office's NTR Position: Q2 2026 in Review

Callan Family Office reduced its Nutrien (NTR) stake by 61% in Q2 2026, selling an estimated $466K and leaving 4,289 shares worth $270K. The position accounts for 0.01% of the portfolio, ranked #1040.

Callan Family Office first reported a position in NTR in Q4 2025 and has held it in 3 quarters since. The position peaked at $825K in Q1 2026. 734 funds tracked by Wall St. Rank hold NTR as of Q2 2026.

  • Callan Family Office held 4,289 shares of Nutrien worth $270K as of Q2 2026.
  • Callan Family Office sold 6,662 Nutrien shares in Q2 2026, an estimated $466K.
  • Nutrien made up 0.01% of Callan Family Office's portfolio in Q2 2026, its #1040 holding.
  • Callan Family Office first reported a position in Nutrien in Q4 2025 and has held it in 3 quarters since.
  • Callan Family Office's Nutrien position peaked at $825K in Q1 2026.
  • 734 funds tracked by Wall St. Rank held Nutrien as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.